참고문헌
- Flohil SC, de Vries E, Neumann HA, Coebergh JW, Nijsten T. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011;91(01):24-30 https://doi.org/10.2340/00015555-1009
- Mendez BM, Thornton JF. Current basal and squamous cell skin cancer management. Plast Reconstr Surg 2018;142(03):373e-387e https://doi.org/10.1097/PRS.0000000000004696
- Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep 2014;3(01):40-45 https://doi.org/10.1007/s13671-014-0069-y
- Dummer R, Karpova MB, Barysch MJ. Basal cell carcinomas: molecular abnormalities and molecularly targeted therapies. Expert Rev Dermatol 2009;4:355-369 https://doi.org/10.1586/edm.09.30
- Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma. Arch Dermatol 1995;131(02):157-163 https://doi.org/10.1001/archderm.1995.01690140041006
- Collins L, Quinn A, Stasko T. Skin cancer and immunosuppression. Dermatol Clin 2018;37(01):83-94 https://doi.org/10.1016/j.det.2018.07.009
- Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006;6(04):295-307 https://doi.org/10.1038/nri1806
- Bos PD, Plitas G, Rudra D, Lee SY, Rudensky AY. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy. J Exp Med 2013;210(11):2435-2466 https://doi.org/10.1084/jem.20130762
- Acarturk TO, Edington H. Nonmelanoma skin cancer. Clin Plast Surg 2005;32(02):237-248
- Beer GM, Bermoser K, Kompatscher P. Closure of nasal defects after tumor excision with local flaps. Aesthetic Plast Surg 1998;22(01):42-47 https://doi.org/10.1007/s002669900164
- Bittner GC, Cerci FB, Kubo EM, Tolkachjov SN. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. An Bras Dermatol 2021;96(03):263-277 https://doi.org/10.1016/j.abd.2020.10.004
- Nahhas AF, Scarbrough CA, Trotter S. A review of the Global guidelines on surgical margins for nonmelanoma skin cancers. J Clin Aesthet Dermatol 2017;10(04):37-46
- Ito T, Inatomi Y, Nagae K, et al. Narrow-margin excision is a safe, reliable treatment for well-defined, primary pigmented basal cell carcinoma: an analysis of 288 lesions in Japan. J Eur Acad Dermatol Venereol 2015;29(09):1828-1831 https://doi.org/10.1111/jdv.12689
- Lin SH, Cheng YW, Yang YC, Ho JC, Lee CH. Treatment of pigmented basal cell carcinoma with 3 mm surgical margin in Asians. BioMed Res Int 2016;2016:7682917 https://doi.org/10.1155/2016/7682917
- Unverdi OF, Yucel S, Berk OS. Recommended surgical margins for basal cell carcinoma. Is 3 mm safe enough? Adv Skin Wound Care 2020;33(04):209-212 https://doi.org/10.1097/01.ASW.0000655496.18027.59
- Quazi SJ, Aslam N, Saleem H, Rahman J, Khan S. Surgical margin of excision in basal cell carcinoma: a systematic review of literature. Cureus 2020;12(07):e9211 https://doi.org/10.7759/cureus.9211
- Chren MM, Linos E, Torres JS, Stuart SE, Parvataneni R, Boscardin WJ. Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol 2013;133(05):1188-1196 https://doi.org/10.1038/jid.2012.403
- Omland SH, Nielsen PS, Gjerdrum LM, Gniadecki R. Immunosuppressive environment in basal cell carcinoma: the role of regulatory T cells. Acta Derm Venereol 2016;96(07):917-921 https://doi.org/10.2340/00015555-2440
- Tomas S. Difficult to diagnose skin cancer-the 'aggressive' BCC. Aust Fam Physician 2009;38(07):492-497
- Argenziano G, Soyer HP, Chimenti S, et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting via the Internet. J Am Acad Dermatol 2003;48(05):679-693 https://doi.org/10.1067/mjd.2003.281